Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Therapeutic Innovation & Regulatory Science
|
July 27, 2018
Evaluating the Completeness of ClinicalTrials.gov
Stella Stergiopoulos, Kenneth A Getz, Christine Blazynski
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
Quantifying Patient Subpopulation Disparities in New Drugs and Biologics Approved Between 2007 and 2017
Kenneth A Getz, Zachary P Smith, Yaritza Peña
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
The Impact of Collaborative and Risk-Sharing Innovation Approaches on Clinical and Regulatory Cycle Times
Joseph A DiMasi, Jennifer Kim, Kenneth A Getz
American Journal of Therapeutics
|
September 27, 2012
Evaluating the completeness and accuracy of MedWatch data
Kenneth A Getz, Stella Stergiopoulos, Kenneth I Kaitin
Clinical Therapeutics
|
May 15, 2018
Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing
Joseph A DiMasi, Zachary Smith, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Analysis of Review Times for Recent 505(b)(2) Applications
Sharon Sakai, Joseph A DiMasi, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
May 21, 2024
New Estimates on the Cost of a Delay Day in Drug Development
Zachary P Smith, Joseph A DiMasi, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Generational Value Differences Affecting Public Perceptions of and Willingness to Participate in Clinical Trials
April M Nelson, Irwin G Martin, Kenneth A Getz
Clinical Therapeutics
|
December 3, 2014
Taking the pulse of strategic outsourcing relationships
Kenneth A Getz, Mary Jo Lamberti, Kenneth I Kaitin
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Mobile Nurse Services in Clinical Trials: Usage and Industry Perceptions
Stella Stergiopoulos, Conor Eustace, Komathi Stem, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Therapeutic Innovation & Regulatory Science
|
July 27, 2018
Evaluating the Completeness of ClinicalTrials.gov
Stella Stergiopoulos, Kenneth A Getz, Christine Blazynski
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
Quantifying Patient Subpopulation Disparities in New Drugs and Biologics Approved Between 2007 and 2017
Kenneth A Getz, Zachary P Smith, Yaritza Peña
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
The Impact of Collaborative and Risk-Sharing Innovation Approaches on Clinical and Regulatory Cycle Times
Joseph A DiMasi, Jennifer Kim, Kenneth A Getz
American Journal of Therapeutics
|
September 27, 2012
Evaluating the completeness and accuracy of MedWatch data
Kenneth A Getz, Stella Stergiopoulos, Kenneth I Kaitin
Clinical Therapeutics
|
May 15, 2018
Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing
Joseph A DiMasi, Zachary Smith, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Analysis of Review Times for Recent 505(b)(2) Applications
Sharon Sakai, Joseph A DiMasi, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
May 21, 2024
New Estimates on the Cost of a Delay Day in Drug Development
Zachary P Smith, Joseph A DiMasi, Kenneth A Getz
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Generational Value Differences Affecting Public Perceptions of and Willingness to Participate in Clinical Trials
April M Nelson, Irwin G Martin, Kenneth A Getz
Clinical Therapeutics
|
December 3, 2014
Taking the pulse of strategic outsourcing relationships
Kenneth A Getz, Mary Jo Lamberti, Kenneth I Kaitin
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Mobile Nurse Services in Clinical Trials: Usage and Industry Perceptions
Stella Stergiopoulos, Conor Eustace, Komathi Stem, et al.
Page
of 4